Literature DB >> 4978880

Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

R A Finkelstein, J J LoSpalluto.   

Abstract

Choleragen, a diarrheagenic protein enterotoxin elaborated by Vibrio cholerae, has been isolated from the supernate of fermenter cultures by steps involving ammonium sulfate precipitation, DEAE cellulose, Sephadex G-75, and Agarose A-5m chromatography. The resulting product appears to be pure according to immunoelectrophoretic, disc electrophoretic, ultracentrifugal, and immunologic criteria. Sephadex gel filtration and membrane filtration studies suggest a molecular size of 61,000. The isolated product is highly active in inducing experimental cholera in infant and adult rabbit models. It also elicits, in small dosage, an increased vascular permeability in skin. These observations indicate that choleragenicity and increased vascular permeability are intimately associated phenomena and may be manifestations of the same basic mechanism. An additional, antigenically identical, protein has also been isolated by the same procedures. The latter substance, termed "choleragenoid", lacks the permeability effect and choleragenicity of the choleragen moiety. Its size (estimated from Sephadex gel filtration at 42,000) is smaller than that of choleragen and it also differs in charge. Choleragenoid may prove useful as a nontoxic immunogen to protect against pathologic effects of V. cholerae infection.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4978880      PMCID: PMC2138674          DOI: 10.1084/jem.130.1.185

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  Excretion of toxin with stools of cholera patients.

Authors:  M V PANSE; N K DUTTA
Journal:  J Infect Dis       Date:  1961 Jul-Aug       Impact factor: 5.226

Review 3.  Cholera toxins.

Authors:  W Burrows
Journal:  Annu Rev Microbiol       Date:  1968       Impact factor: 15.500

4.  Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A.

Authors:  R A Finkelstein; P Atthasampunna; M Chulasamaya; P Charunmethee
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

5.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

6.  Experimental cholera in humans.

Authors:  C Benyajati
Journal:  Br Med J       Date:  1966-01-15

7.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

8.  Pathogenesis of experimental cholera: identification of choleragen (procholeragen A) by disc immunoelectrophoresis and its differentiation from cholera mucinase.

Authors:  R A Finkelstein; P Z Sobocinski; P Atthasampunna; P Charunmethee
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

9.  Cholera toxins: purification and preliminary characterization of ileal loop reactive type 2 toxin.

Authors:  W H Coleman; J Kaur; M E Iwert; G J Kasai; W Burrows
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

10.  Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.

Authors:  A S Benenson; A Saad; W H Mosley; A Ahmed
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

  10 in total
  107 in total

Review 1.  Bacterial toxins in pediatric infectious diseases.

Authors:  D R Balkundi; A Kumar
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

2.  The role of immune pig colostrum, serum and immunoglobulins IgG, IgM, and IgA, in local intestinal immunity against enterotoxic strain in Escherichia coli O55 in germfree piglets.

Authors:  I Miller; J Cerná; J Trávnícek; J Rejnek; J Kruml
Journal:  Folia Microbiol (Praha)       Date:  1975       Impact factor: 2.099

3.  Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.

Authors:  T Honda; R A Finkelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

4.  Upregulation of virulence genes promotes Vibrio cholerae biofilm hyperinfectivity.

Authors:  A L Gallego-Hernandez; W H DePas; J H Park; J K Teschler; R Hartmann; H Jeckel; K Drescher; S Beyhan; D K Newman; F H Yildiz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-30       Impact factor: 11.205

5.  Purification and characterization of the soluble hemagglutinin (cholera lectin)( produced by Vibrio cholerae.

Authors:  R A Finkelstein; L F Hanne
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Failure of cholera enterotoxin to alter cyclic 3',5'-adenosine monophosphate-mediated responses in toad urinary bladder.

Authors:  P D Lief; G T Keusch
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

7.  Exohemagglutinins: new products of vibrios.

Authors:  K Oishi; S Yokoshima; T Tomiyama; K Aida
Journal:  Appl Environ Microbiol       Date:  1979-07       Impact factor: 4.792

8.  Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

Authors:  C C Häse; L S Thai; M Boesman-Finkelstein; V L Mar; W N Burnette; H R Kaslow; L A Stevens; J Moss; R A Finkelstein
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Lipidation of an FlrC-dependent protein is required for enhanced intestinal colonization by Vibrio cholerae.

Authors:  David C Morris; Fen Peng; Jeffrey R Barker; Karl E Klose
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

10.  Enterotoxic activity of hemolysin BL from Bacillus cereus.

Authors:  D J Beecher; J L Schoeni; A C Wong
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.